LBCA is pleased to welcome Cynthia Blevins Doll, Lisa Pellegrino, and Jane Rozina to its Board of Directors. Our newest Board members bring a range […]
LBCA Welcomes Three New Members to the Board of Directors Read More »
LBCA is excited to announce the launch of its fifth Local Advocacy Team (LAT), the Wisconsin Alliance for Lobular Awareness. Officially recognized in July 2026,
LBCA’s Fifth Local Advocacy Team Launches in Wisconsin Read More »
My name is Betsy. My husband was in the Navy for 30 years, so my cancer experience spans three states. In 2013, my doctor in
My ILC Story: Meet Betsy and Hear Her Lobular Breast Cancer Story Read More »
The third session in LBCA’s Liquid Biopsy Webinar Series, Liquid Biopsy in the Management and Monitoring of Metastatic ILC, is now available to watch on
My name is Famke. I’m originally from Germany and have been living in the U.S. since 2008. I am now in the Bay Area and
My ILC Story: Meet Famke and Hear Her Lobular Breast Cancer Story Read More »
A major milestone for the lobular breast cancer research community was attained with the launch of the Lobular American Research Consortium (LARC), the first national,
Lobular Breast Cancer Alliance (LBCA) is proud to celebrate two members of our team who were recently named to OncoDaily’s 100 Most Influential Cancer Survivors
LBCA Staff Recognized in Oncodaily’s 100 Influential Cancer Survivors on Social Media Read More »
Researchers at the University of Colorado Anschutz Cancer Center have launched the Lobular Breast Cancer Initiative (LBCI), a new interdisciplinary program dedicated to advancing research
New ILC Focused Initiative at University of Colorado Anschutz Cancer Center Read More »
LBCA is excited to welcome Mary Pat Landry to the LBCA Board of Directors. A Louisiana native, Mary earned a Bachelor of Arts in Psychology
LBCA Welcomes New Board Member Mary Pat Landry Read More »
LBCA is thrilled to welcome Lauren Sebesta as Manager of Marketing and Communications. Lauren holds a Bachelor of Arts in Biology from Binghamton University and
LBCA Welcomes New Staff Member Lauren Sebesta, Marketing & Communications Manager Read More »
LBCA advocates continue to raise awareness and educate about lobular breast cancer through local events! New York We applaud Maureen Terranova who spread the word
Advocacy in Action in New York and Montana Read More »
LBCA Scientific Advisory Board member, Dr. George Sflomos, recently published a research article LOX Inhibition Disrupts a Collagen–Integrin–MYC Axis to Suppress Progression of Invasive Lobular
LBCA encourages ILC patients to participate in breast cancer clinical trials to help ensure that there is sufficient participation by those with ILC to enable
"*" indicates required fields
